Two companies were added to Russell 3000 indexes today: Uroplasty Inc. (NSDQ:UPI) joined the global index, and Delcath Systems Inc. (NSDQ:DCTH) joined the lower third of the U.S. index.
Uroplasty and Delcath become the latest addition to the Russell 3000 index, a measure of the 3,000 largest companies representing 98 percent of the investable equity in the U.S. market. Russell indices are often used by investment managers and institutional investors as a benchmark for active and passive investment.
Uroplasty, a Minn.-based incontinence treatment maker, will also be added to the Russell Global index, which follows approximately 10,000 international securities representing 98 percent of the investable global market.
Uroplasty beat Wall Street and closed near its all-time high for its fourth quarter and full year fiscal year 2011.
Delcath, maker of oncology devices and pharmaceuticals, will join the Microcap list, which represents the 1,000 smallest companies on the Russell index.
The New York-based cancer device maker won CE Mark approval in the European Union for its Hepatic Chemostat chemotherapy delivery device in April.
The index changes will go into effect after the close of trading on Friday, June 24.
